About SiMPore
SiMPore, headquartered in Rochester, New York, is developing a novel membrane filter. This technology offers unparalleled precision in separation and purification with applications ranging from drug development to nanotechnology.
Management Team
Rick Richmond, President and CEO
Rick Richmond serves as CEO for SiMPore on an interim and part-time basis. Formerly, Mr. Richmond was co-founder and CEO of STS Biopolymers Inc., a developer and supplier of polymeric coatings for medical devices. Mr. Richmond expanded STS Biopolymers from a 2-person R&D shop into a 46-person R&D, licensing and production operation. The Company had customers in North America, Europe and Asia, and became the second largest supplier of specialty medical device coatings. After a successful sale of STS Biopolymers, Mr. Richmond has served as Entrepreneur-in-Residence at High Technology of Rochester, a non-profit business incubator. Prior to founding STS Biopolymers, Mr. Richmond was Executive VP at STS duoTek and also held executive level positions at Nalge Nunc Inc.
Christopher Striemer, Vice President, Membrane Development
Dr. Chris Striemer received his doctorate in Electrical and Computer Engineering at the University of Rochester in 2004. As the original inventor of the membrane technology, Chris holds several patents and has received speaking invitations at international technology meetings. Chris has also held a senior technical and management position at an optical biosensor company.
Thomas Gaborski, Vice President, Life Sciences
Thomas Gaborski completed his PhD in Biomedical Engineering at the University of Rochester in 2008. He earned a BS degree in Biological and Environmental Engineering from Cornell University in 2002 and his MS degree in Biomedical Engineering from the University of Rochester in 2004. In the area of nanoscale biomaterials, Tom has co-authored one patent and has two more pending.
James Roussie, Director of Sales and Marketing
Dr. James Roussie received his doctorate in Biochemistry from the University of Rochester in 2005. After completing his doctorate, Jamie worked in the Office of Corporate Alliances (OCA) at the University of Rochester Medical Center. He also received a M.S. degree in the Science & Technology Commercialization program at the University of Texas at Austin.
James McGrath, Director of Academic Alliances
Professor McGrath is an Associate Professor of Biomedical Engineering at the University of Rochester. Dr. McGrath holds degrees from MIT in both Mechanical Engineering (MS in 1994) and Biological Engineering (PhD in 1998). He leads the Nanomembrane Research Group (NRG) at the University of Rochester, comprising of more than fifteen students, scientists and professors.